Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin Matentzoglu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical Society Transactions|September 17, 2008
Ubiquitin ligase E6-AP and its role in human diseaseKonstantin Matentzoglu, Martin Scheffner
Biotechniques|March 24, 2009
Ubiquitin-fusion protein system: a powerful tool for ectopic protein expression in mammalian cellsKonstantin Matentzoglu, Martin Scheffner
The Journal of Biological Chemistry|November 7, 2006
The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteinsPetric Kuballa, Konstantin Matentzoglu, Martin Scheffner
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2013
Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein ArcSimone Kühnle, Benedikt Mothes, Konstantin Matentzoglu, et al.
The Journal of General Virology|October 20, 2007
Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomavirusesStephanie Töpffer, Andreas Müller-Schiffmann, Konstantin Matentzoglu, et al.
The Journal of Biological Chemistry|April 16, 2011
Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2Simone Kühnle, Ulrike Kogel, Sandra Glockzin, et al.
The Journal of Biological Chemistry|June 21, 2007
UBE1L2, a novel E1 enzyme specific for ubiquitinChristiane Pelzer, Ingrid Kassner, Konstantin Matentzoglu, et al.
Journal of Medical Genetics|December 18, 2012
Mutation of HERC2 causes developmental delay with Angelman-like featuresGaurav V Harlalka, Emma L Baple, Harold Cross, et al.
Cell|May 20, 2008
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networksAnthony G Uren, Jaap Kool, Konstantin Matentzoglu, et al.
Cancer Research|January 14, 2010
Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypesJaap Kool, Anthony G Uren, Carla P Martins, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical Society Transactions|September 17, 2008
Ubiquitin ligase E6-AP and its role in human diseaseKonstantin Matentzoglu, Martin Scheffner
Biotechniques|March 24, 2009
Ubiquitin-fusion protein system: a powerful tool for ectopic protein expression in mammalian cellsKonstantin Matentzoglu, Martin Scheffner
The Journal of Biological Chemistry|November 7, 2006
The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteinsPetric Kuballa, Konstantin Matentzoglu, Martin Scheffner
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2013
Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein ArcSimone Kühnle, Benedikt Mothes, Konstantin Matentzoglu, et al.
The Journal of General Virology|October 20, 2007
Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomavirusesStephanie Töpffer, Andreas Müller-Schiffmann, Konstantin Matentzoglu, et al.
The Journal of Biological Chemistry|April 16, 2011
Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2Simone Kühnle, Ulrike Kogel, Sandra Glockzin, et al.
The Journal of Biological Chemistry|June 21, 2007
UBE1L2, a novel E1 enzyme specific for ubiquitinChristiane Pelzer, Ingrid Kassner, Konstantin Matentzoglu, et al.
Journal of Medical Genetics|December 18, 2012
Mutation of HERC2 causes developmental delay with Angelman-like featuresGaurav V Harlalka, Emma L Baple, Harold Cross, et al.
Cell|May 20, 2008
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networksAnthony G Uren, Jaap Kool, Konstantin Matentzoglu, et al.
Cancer Research|January 14, 2010
Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypesJaap Kool, Anthony G Uren, Carla P Martins, et al.
Pageof 1